Abstract
Leptomeningeal involvement in patients with CLL is relatively rare and the prognosis is usually considered to be poor. The authors reviewed all CLL patients treated in a tertiary referral center to assess the incidence and outcome of leptomeningeal involvement (LI) in CLL. They found an incidence of 1-2% of LI. Most of the patients with LI had a longterm survival, despite failure to clear the cerebrospinal fluid from tumor cells.
MeSH terms
-
Aged
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Arachnoid / drug effects
-
Arachnoid / pathology
-
Arachnoid / radiation effects
-
Cohort Studies
-
Comorbidity
-
Dementia, Vascular / etiology
-
Humans
-
Incidence
-
Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy
-
Leukemia, Lymphocytic, Chronic, B-Cell / mortality*
-
Leukemia, Lymphocytic, Chronic, B-Cell / radiotherapy
-
Male
-
Meningeal Neoplasms / drug therapy
-
Meningeal Neoplasms / mortality*
-
Meningeal Neoplasms / radiotherapy
-
Meningeal Neoplasms / secondary*
-
Meninges / drug effects
-
Meninges / pathology*
-
Meninges / radiation effects
-
Middle Aged
-
Pia Mater / drug effects
-
Pia Mater / pathology
-
Pia Mater / radiation effects
-
Radiotherapy / adverse effects
-
Radiotherapy / methods
-
Retrospective Studies
-
Survival Rate
-
Treatment Outcome